DRW Holdings »

Aligos Therapeutics shares owned by DRW Holdings

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by DRW Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $111k 12k 9.32

More positions owned by DRW Holdings

iShares Russell 2000 Index Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Bitcoin Trust Etf Common Call Option (IBIT)
Tesla Motors Call Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Apple Call Option (AAPL)
Astrazeneca Sponsored Adr Call Option
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
NVIDIA Corporation Call Option (NVDA)
Qualcomm Call Option (QCOM)
Freeport-mcmoran CL B Call Option (FCX)
Spdr Gold Tr Gold Shs (GLD)
Ishares Msci Taiwan Etf (EWT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)

View all positions for DRW Holdings

Top funds holding Aligos Therapeutics

Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Woodline Partners
Marshall Wace
Vanguard Group
Adage Capital Partners GP
Renaissance Technologies
Baker Bros. Advisors
Hillhouse Capital Advisors
Verition Fund Management
LPL Financial
Geode Capital Management
Two Sigma Investments
Jane Street

View all funds holding Aligos Therapeutics